More than a dozen children in the Tampa, Florida area with muscular dystrophy, Down’s syndrome, and other neuromuscular disorders will soon…
Articles by Margarida Azevedo, MSc
Regenerative medicine is a branch of research that deals with the process of replacing, engineering or regenerating human cells, tissues, or…
Catabasis Pharmaceuticals, Inc., recently announced that the first part of its MoveDMD clinical trial, a Phase 1/2 study of CAT-1004 in…
Duke University graduate student Mark Juhas is engineering a highly functional skeletal muscle tissue that has shown great promise and might constitute…
Lochte Insurance Agency is organizing a charity drive to raise awareness and support for the San Antonio Muscle…
Debra Miller, CEO and founder of CureDuchenne, a nonprofict dedicated to researching cures for Duchenne muscular dystrophy, recently released a…
BioMarin Pharmaceutical, Inc., announced that a Complete Response letter has been issued by the U.S. Food and Drug Administration…
The Grünenthal Group, an international research and development pharmaceutical company, announced it is developing its Duchenne muscular dystrophy (DMD) medicine HT-100…
Researchers have found that clinically significant findings of cardiac arrhythmia, as measured by Holter findings, are rare even among young Duchenne…
A drug used to treat leukemia might be a potential therapy to slow the progression of Duchenne muscular dystrophy (DMD), according to the…